ANIX – Anixa Biosciences Inc
Float Short %
3.18
Margin Of Safety %
Put/Call OI Ratio
0.1
EPS Next Q Diff
EPS Last/This Y
-0.04
EPS This/Next Y
0.02
Price
3.3
Target Price
11
Analyst Recom
1
Performance Q
-21.05
Relative Volume
0.68
Beta
0.54
Ticker: ANIX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | ANIX | 3.2 | 0.04 | 0.11 | 8370 |
| 2025-12-29 | ANIX | 3.19 | 0.04 | 0.00 | 8388 |
| 2025-12-30 | ANIX | 3.12 | 0.04 | 0.00 | 8375 |
| 2025-12-31 | ANIX | 3.08 | 0.04 | 0.02 | 8447 |
| 2026-01-02 | ANIX | 3.16 | 0.04 | 0.01 | 8387 |
| 2026-01-05 | ANIX | 3.18 | 0.04 | 0.00 | 8380 |
| 2026-01-06 | ANIX | 3.18 | 0.04 | 0.00 | 8378 |
| 2026-01-07 | ANIX | 3.28 | 0.04 | 0.10 | 8382 |
| 2026-01-08 | ANIX | 3.41 | 0.04 | 0.03 | 8435 |
| 2026-01-09 | ANIX | 3.4 | 0.04 | 0.05 | 8730 |
| 2026-01-12 | ANIX | 3.16 | 0.04 | 0.00 | 8814 |
| 2026-01-13 | ANIX | 3.29 | 0.04 | 0.01 | 8828 |
| 2026-01-14 | ANIX | 3.31 | 0.03 | 0.04 | 9045 |
| 2026-01-15 | ANIX | 3.22 | 0.03 | 0.60 | 9013 |
| 2026-01-16 | ANIX | 3.19 | 0.04 | 0.05 | 9020 |
| 2026-01-20 | ANIX | 3.11 | 0.10 | 0.00 | 2467 |
| 2026-01-21 | ANIX | 3.17 | 0.10 | 0.25 | 2474 |
| 2026-01-22 | ANIX | 3.3 | 0.10 | 0.00 | 2478 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | ANIX | 3.20 | 0.0 | - | -0.35 |
| 2025-12-29 | ANIX | 3.18 | 0.0 | - | -0.35 |
| 2025-12-30 | ANIX | 3.12 | 0.0 | - | -0.35 |
| 2025-12-31 | ANIX | 3.10 | 0.0 | - | -0.35 |
| 2026-01-02 | ANIX | 3.16 | 0.0 | - | -0.35 |
| 2026-01-05 | ANIX | 3.19 | 0.0 | - | -0.35 |
| 2026-01-06 | ANIX | 3.18 | 0.0 | - | -0.35 |
| 2026-01-07 | ANIX | 3.28 | 0.0 | - | -0.35 |
| 2026-01-08 | ANIX | 3.41 | 0.0 | - | -0.35 |
| 2026-01-09 | ANIX | 3.38 | 0.0 | - | -0.35 |
| 2026-01-12 | ANIX | 3.16 | 0.0 | - | -0.35 |
| 2026-01-13 | ANIX | 3.28 | 0.0 | - | -0.35 |
| 2026-01-14 | ANIX | 3.32 | 0.0 | - | -0.35 |
| 2026-01-15 | ANIX | 3.23 | 0.0 | - | -0.35 |
| 2026-01-16 | ANIX | 3.19 | 0.0 | - | -0.38 |
| 2026-01-20 | ANIX | 3.11 | 0.0 | - | -0.38 |
| 2026-01-21 | ANIX | 3.16 | 0.0 | - | -0.38 |
| 2026-01-22 | ANIX | 3.30 | 0.0 | - | -0.38 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | ANIX | 1.99 | 0.37 | 2.56 |
| 2025-12-29 | ANIX | 1.99 | 0.37 | 2.56 |
| 2025-12-30 | ANIX | 1.99 | 0.37 | 2.56 |
| 2025-12-31 | ANIX | 1.99 | 0.37 | 2.56 |
| 2026-01-02 | ANIX | 1.99 | 0.37 | 2.56 |
| 2026-01-05 | ANIX | 1.99 | 0.37 | 2.56 |
| 2026-01-06 | ANIX | 1.99 | 0.37 | 2.56 |
| 2026-01-07 | ANIX | 1.99 | 0.37 | 2.56 |
| 2026-01-08 | ANIX | 1.99 | 0.37 | 2.56 |
| 2026-01-09 | ANIX | 1.99 | 0.37 | 2.56 |
| 2026-01-12 | ANIX | 1.97 | 0.36 | 2.56 |
| 2026-01-13 | ANIX | 1.99 | 0.36 | 3.22 |
| 2026-01-14 | ANIX | 1.99 | 0.36 | 3.22 |
| 2026-01-15 | ANIX | 1.68 | 0.36 | 3.18 |
| 2026-01-16 | ANIX | 1.11 | 0.36 | 3.18 |
| 2026-01-20 | ANIX | 1.11 | 0.35 | 3.18 |
| 2026-01-21 | ANIX | 1.11 | 0.35 | 3.18 |
| 2026-01-22 | ANIX | 0.83 | 0.35 | 3.18 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.1
Avg. EPS Est. Next Quarter
-0.1
Insider Transactions
0.83
Institutional Transactions
0.35
Beta
0.54
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
7
Growth Score
19
Sentiment Score
49
Actual DrawDown %
59.2
Max Drawdown 5-Year %
-70.2
Target Price
11
P/E
Forward P/E
PEG
P/S
P/B
7.19
P/Free Cash Flow
EPS
-0.34
Average EPS Est. Cur. Y
-0.38
EPS Next Y. (Est.)
-0.36
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.68
Return on Equity vs Sector %
-99.3
Return on Equity vs Industry %
-83.4
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Anixa Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 4
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
stock quote shares ANIX – Anixa Biosciences Inc Stock Price stock today
news today ANIX – Anixa Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ANIX – Anixa Biosciences Inc yahoo finance google finance
stock history ANIX – Anixa Biosciences Inc invest stock market
stock prices ANIX premarket after hours
ticker ANIX fair value insiders trading